Insider trades
Mark A. Velleca, CEO of Black Diamond Therapeutics BDTX, has filed 0 purchases and 2 sales on the open market. The latest trade was on 01/21.
Mark A. Velleca
President & CEO
- First filing
- 23/03/20
- Trades
- 15 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- No record
- Last trade
- 01/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 23/08/08 | 23/08/10 | 60,000 sh2 trades | $2.00avg. | $120,054.28 | −34.1% |